Today, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.
Dominique Muszinski
Advertisement
Articles by Dominique Muszinski
Advertisement
Latest Updated Articles
Sponsors Ask: Is Our Trial Plan Realistic? Toward a Data-Driven Feasibility AssessmentPublished: December 21st 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
2025 SCRS Global Site Solutions Summit: How to Streamline Site Qualification and Initiation Training
4
AI in Action: Breaking Down Clinical Trial Bottlenecks
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
